Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
250.43
+7.82 (3.22%)
Apr 25, 2025, 1:38 PM EDT - Market open
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
24
Consensus Rating
Strong Buy
Price Target
$322.39
Upside
+28.73%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $284 → $268 | Hold | Maintains | $284 → $268 | +7.02% | Apr 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +27.78% | Apr 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $500 | Strong Buy | Reiterates | $500 | +99.66% | Apr 2, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $338 → $342 | Buy | Maintains | $338 → $342 | +36.57% | Mar 31, 2025 |
| Redburn Atlantic | Redburn Atlantic | Strong Buy Initiates $353 | Strong Buy | Initiates | $353 | +40.96% | Mar 31, 2025 |
| Stifel | Stifel | Strong Buy Maintains $300 → $345 | Strong Buy | Maintains | $300 → $345 | +37.76% | Mar 31, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $280 → $328 | Hold → Buy | Upgrades | $280 → $328 | +30.97% | Mar 24, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $338 → $351 | Strong Buy | Maintains | $338 → $351 | +40.16% | Mar 21, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $385 → $390 | Strong Buy | Maintains | $385 → $390 | +55.73% | Mar 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $310 → $330 | Buy | Maintains | $310 → $330 | +31.77% | Mar 21, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $300 → $338 | Buy | Maintains | $300 → $338 | +34.97% | Mar 21, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $275 → $287 | Hold | Maintains | $275 → $287 | +14.60% | Mar 21, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $302 → $325 | Strong Buy | Maintains | $302 → $325 | +29.78% | Mar 21, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $300 | Strong Buy | Maintains | $300 | +19.79% | Mar 21, 2025 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +27.78% | Mar 21, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $272 → $280 | Hold | Maintains | $272 → $280 | +11.81% | Mar 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.